Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GEMAYEL GEORGES | Director | Sep 13 '24 | Option Exercise | 11.46 | 10,000 | 114,600 | 23,315 | Sep 17 04:10 PM | GEMAYEL GEORGES | Director | Sep 13 '24 | Sale | 31.33 | 13,886 | 435,048 | 13,315 | Sep 17 04:10 PM | GEORGES GEMAYEL | Director | Sep 13 '24 | Proposed Sale | 31.33 | 13,886 | 435,041 | | Sep 13 04:30 PM | Khattar Jack A. | President, CEO | Sep 03 '24 | Option Exercise | 0.00 | 21,000 | 0 | 936,217 | Sep 03 05:00 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Aug 20 '24 | Option Exercise | 0.00 | 1,250 | 0 | 10,251 | Aug 20 05:00 PM | TAMI TILLOTSON MARTIN | Former Officer | Aug 02 '24 | Proposed Sale | 29.02 | 4,000 | 116,074 | | Aug 02 04:16 PM | TAMI TILLOTSON MARTIN | Former Officer | Aug 01 '24 | Proposed Sale | 29.31 | 3,100 | 90,856 | | Aug 01 04:19 PM | TAMI TILLOTSON MARTIN | Former Officer | Jul 31 '24 | Proposed Sale | 30.13 | 5,000 | 150,650 | | Jul 31 04:41 PM | TAMI TILLOTSON MARTIN | Former Officer | Jul 30 '24 | Proposed Sale | 30.56 | 2,900 | 88,610 | | Jul 30 04:02 PM | TAMI TILLOTSON MARTIN | Former Officer | Jul 29 '24 | Proposed Sale | 30.75 | 5,000 | 153,750 | | Jul 29 04:08 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 21 '24 | Option Exercise | 25.30 | 14,491 | 366,622 | 23,061 | Mar 25 05:00 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 21 '24 | Sale | 35.31 | 14,491 | 511,677 | 8,570 | Mar 25 05:00 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 20 '24 | Option Exercise | 25.30 | 400 | 10,120 | 8,970 | Mar 22 05:00 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 20 '24 | Sale | 35.31 | 400 | 14,124 | 8,570 | Mar 22 05:00 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 19 '24 | Option Exercise | 25.30 | 12,364 | 312,809 | 20,934 | Mar 21 05:01 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 19 '24 | Sale | 35.31 | 12,364 | 436,573 | 8,570 | Mar 21 05:01 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 13 '24 | Option Exercise | 17.61 | 62,366 | 1,098,523 | 44,686 | Mar 15 06:39 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 13 '24 | Sale | 33.74 | 62,366 | 2,104,289 | 8,570 | Mar 15 06:39 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 12 '24 | Option Exercise | 12.98 | 3,884 | 50,414 | 12,454 | Mar 14 05:00 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Mar 12 '24 | Sale | 32.99 | 3,884 | 128,133 | 8,570 | Mar 14 05:00 PM | Mottola Frank | SVP, Quality, GMP, Ops, IT | Feb 28 '24 | Option Exercise | 0.00 | 990 | 0 | 8,239 | Feb 29 05:01 PM | Khattar Jack A. | President, CEO | Feb 28 '24 | Option Exercise | 0.00 | 35,000 | 0 | 932,005 | Feb 29 05:00 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Feb 26 '24 | Option Exercise | 9.13 | 5,000 | 45,650 | 13,570 | Feb 28 05:01 PM | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Feb 26 '24 | Sale | 30.21 | 5,000 | 151,050 | 8,570 | Feb 28 05:01 PM | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Jan 10 '24 | Option Exercise | 9.24 | 8,000 | 73,920 | 93,664 | Jan 12 05:00 PM | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | Jan 10 '24 | Sale | 27.91 | 8,000 | 223,280 | 85,664 | Jan 12 05:00 PM | Rubin Jonathan | Sr. VP, Chief Medical Officer | Dec 22 '23 | Option Exercise | 0.00 | 600 | 0 | 3,447 | Dec 26 05:01 PM | Khattar Jack A. | President, CEO | Dec 22 '23 | Option Exercise | 0.00 | 25,000 | 0 | 892,463 | Dec 26 05:00 PM | NEWHALL CHARLES W III | Director | Nov 16 '23 | Option Exercise | 9.24 | 7,457 | 68,903 | 119,589 | Nov 20 05:00 PM | NEWHALL CHARLES W III | Director | Nov 16 '23 | Sale | 28.01 | 2,500 | 70,025 | 117,089 | Nov 20 05:00 PM | Hudson Frederick M. | Director | Nov 15 '23 | Option Exercise | 9.24 | 7,457 | 68,903 | 42,324 | Nov 17 05:00 PM | Hudson Frederick M. | Director | Nov 15 '23 | Sale | 28.50 | 9,093 | 259,150 | 33,231 | Nov 17 05:00 PM | Mottola Frank | SVP, Quality, GMP, Ops, IT | Nov 14 '23 | Option Exercise | 9.24 | 2,000 | 18,480 | 6,791 | Nov 16 05:00 PM | Mottola Frank | SVP, Quality, GMP, Ops, IT | Nov 14 '23 | Sale | 28.13 | 1,110 | 31,224 | 5,681 | Nov 16 05:00 PM | DEC TIMOTHY C | Senior Vice-President & CFO | Oct 13 '23 | Option Exercise | 0.00 | 4,000 | 0 | 7,000 | Oct 13 05:00 PM |
|